Myocardial infarction and gut micro biota: An incidental connection
The main therapeutic goal of modern cardiology is to develop novel approaches to minimize inflammation, myocardial necrosis/apoptosis, and enhance cardiac repair after MI. Though MI can be affected by genetic and environmental factors, the search for targeting lifestyle factors has been of greater interest. One such potential factor is the micro biota, the human intestinal microbial community. The disruption of intestinal flora structure provokes MI and poor prognosis. Since gut micro biota is readily modifiable through a variety of interventions, it can be targeted to modulate the host signalling pathways involved in inflammation and MI pathogenesis. Symbiosis bacteria can reduce ischemia/reperfusion injury and inflammation; moreover, they can regulate lipid metabolism, blood pressure, apoptosis, MI size, and overall cardiac survival. In this review, we provide an overview of the development of MI following the symbiosis micro biota and give an update on a micro biota-based therapeutic strategy to delay or prevent MI.
- Atherosclerosis
- Probiotics
- Cardiovascular diseases
- Dysbiosis of gut microbiota
- Symbiosis bacteria
- Inflammation
Related Conference of Myocardial infarction and gut micro biota: An incidental connection
10th International Congress on Trauma, Critical Care and Emergency Medicine
19th International Conference on Virology, Emerging Diseases & vaccines
7th International Conference on Antimicrobial and Antibacterial Agents
7th International Conference on Clinical Microbiology, Virology and Infectious Diseases
Myocardial infarction and gut micro biota: An incidental connection Conference Speakers
Recommended Sessions
- Animals in a bacterial world, a new imperative for life sciences
- Applied Microbiology in Animals
- Bioinformatics for Micro biome
- Forensic Microbiology
- Geomicrobiology
- Gut Micro biota
- Host pathogen Interaction
- Human Micro biota
- Industrial Microbiology & Food Microbiology
- Industrial Microbiology and Future Bio industries
- Microbiology & Microbes World
- Molecular Bio robotics
- Myocardial infarction and gut micro biota: An incidental connection
- Oral Microbiology
- Paleomicrobiology, Archaeomicrobiology & Microbial Forensics
- Petroleum and Biofuels Microbiology
- Pharmaceutical Microbiology
- Prebiotics and Probiotics
- Public Health & Epidemiology
- Soil Microbiology
Related Journals
Are you interested in
- Agriculture & Forest Microbiology - Microbiology 2024 (Switzerland)
- Agriculture Microbiology - Beneficial Microbes 2024 (Ireland)
- Antimicrobial Agents & Resistance - Microbiology 2024 (Switzerland)
- Applied and Environmental Science - Microbiology 2024 (Switzerland)
- Aquatic & Marine Microbiology - Microbiology 2024 (Switzerland)
- Bacteriology, Bacterial Pathogens & Associated diseases - Microbiology 2024 (Switzerland)
- Beneficial Microbes in the environment - Beneficial Microbes 2024 (Ireland)
- Biological Need of Trauma - TRAUMA 2024 (Netherlands)
- Blunt Trauma - TRAUMA 2024 (Netherlands)
- Cellular Microbiology & Systems Microbiology - Microbiology 2024 (Switzerland)
- Clinical and Neuro Virology - Virology-2024 (Canada)
- Clinical and Public Health Microbiology - Microbiology 2024 (Switzerland)
- Clinical Infections and Vaccines - Microbiology 2024 (Switzerland)
- Corona Virus - Virology-2024 (Canada)
- Critical Care in Trauma - TRAUMA 2024 (Netherlands)
- Delirium in Critical Care - TRAUMA 2024 (Netherlands)
- Ecology and Evolution of Microbe-Host Interactions - Beneficial Microbes 2024 (Ireland)
- Elderly Trauma and Critical Care - TRAUMA 2024 (Netherlands)
- Engineering Beneficial Microbes - Beneficial Microbes 2024 (Ireland)
- Environmental Microbiology (Soil Microbiology & Water Microbiology) - Microbiology 2024 (Switzerland)
- Evolution in Emergency Medicine Practices - TRAUMA 2024 (Netherlands)
- General Virology - Virology-2024 (Canada)
- HIV/AIDS and Sexually Transmitted Infections - Virology-2024 (Canada)
- Immunization and Immunotherapeutics - Virology-2024 (Canada)
- Immunobiotics - Beneficial Microbes 2024 (Ireland)
- Industrial Microbiology, Microbial Biotechnology and Future Bioindustries - Microbiology 2024 (Switzerland)
- Influenza and other Respiratory Diseases - Virology-2024 (Canada)
- Intensive Care in Trauma - TRAUMA 2024 (Netherlands)
- Marine Microbiology - Beneficial Microbes 2024 (Ireland)
- Medical Parasitology - Microbiology 2024 (Switzerland)
- Microbial Cytology, Microbial Physiology & Recombination DNA - Microbiology 2024 (Switzerland)
- Microbial Ecology and Evolution - Microbiology 2024 (Switzerland)
- Microbial Infections - Virology-2024 (Canada)
- Microbiome - Beneficial Microbes 2024 (Ireland)
- Molecular Microbiology - Microbiology 2024 (Switzerland)
- Mycology, Fungal Pathogens and Associated Diseases - Microbiology 2024 (Switzerland)
- New and Endogenous Retroviruses - Virology-2024 (Canada)
- New Technology in Trauma - TRAUMA 2024 (Netherlands)
- Novel Antiviral Therapies - Virology-2024 (Canada)
- Novel Vaccine Delivery Methods - Virology-2024 (Canada)
- Obstetric Trauma - TRAUMA 2024 (Netherlands)
- Paediatric Trauma - TRAUMA 2024 (Netherlands)
- Pathogenic Microbes in Immunology and Microbiology - Beneficial Microbes 2024 (Ireland)
- Pathogenic Microbes in Medicine and Dentistry - Beneficial Microbes 2024 (Ireland)
- Plant Pathology & Microbiology - Microbiology 2024 (Switzerland)
- Probiotics & Prebiotics - Beneficial Microbes 2024 (Ireland)
- Psychological Trauma - TRAUMA 2024 (Netherlands)
- Soil biological management - Beneficial Microbes 2024 (Ireland)
- Structural and Molecular virology - Virology-2024 (Canada)
- Transmission of Viruses - Virology-2024 (Canada)
- Transplant-Associated Viral Infections - Virology-2024 (Canada)
- Trauma & Critical Care Nursing - TRAUMA 2024 (Netherlands)
- Trauma Emergency Medicine - TRAUMA 2024 (Netherlands)
- Trauma in Nursing & Midwifery - TRAUMA 2024 (Netherlands)
- Trauma Therapy - TRAUMA 2024 (Netherlands)
- Trauma-An International Perspective - TRAUMA 2024 (Netherlands)
- Trauma-Mass Casualties Incidents - TRAUMA 2024 (Netherlands)
- Vaccines against Emerging Diseases (Ebola/Zika/Dengue/Chik) - Virology-2024 (Canada)
- Vaccines and the Microbiome - Virology-2024 (Canada)
- Veterinary Microbiology - Microbiology 2024 (Switzerland)
- Veterinary virology - Virology-2024 (Canada)
- Viral Genetics, Evolution and Dynamics - Virology-2024 (Canada)
- Viral Immunology and Immunopathology - Virology-2024 (Canada)
- Viral Oncology - Virology-2024 (Canada)
- Viral Pathogenesis - Virology-2024 (Canada)
- Virology, Viral Pathogens and Associated Diseases - Microbiology 2024 (Switzerland)